No Time, Still a Final: The Empty Cell in Naomi Korir's Data

On the Glasgow track, a middle-distance runner came through the final bend. The race ended. The board read fifth. And then? Nothing. No time, no splits, no wind reading, no season's best. As an athletics data analyst, that empty cell is what stops me first. Because the first column of every table I keep is the mark—and here that exact column is blank.

A placing is information. But it is incomplete information. A placing tells you who finished ahead; a performance tells you how fast. With one and not the other, you can call someone elite—but that is an estimate, not evidence.

This is not a trophy story. It is a story about an empty cell—the cell between a placing and a performance, the cell between a condition and a record.

Naomi Korir's story is, at its core, a human-interest medical report, not a performance report. She is a Kenyan middle-distance runner, aged twenty-eight. She was born with a congenital fistula, which causes continuous urine leakage. She has said herself that the urine is flowing continuously, and that it is bad. To reduce the leaking, she shortened her running distances. She has also said that most people avoided her, and that she used sport so she would not feel excluded.

From years of standing at the rail watching races, I have learned one thing: sports reporting comes in two kinds—one measures a result, the other measures a person. Korir's report is the second kind. The problem is that when a reader sees the phrase Commonwealth Games finalist, they also import a performance claim. That is where data and sympathy meet head-on.

The context needs cleaning up. The Commonwealth Games is a Tier-2 multi-sport event, below the Olympics and the World Championships. Fifth in a final here is a credible international standard, but it is below medal level. And there is a technical point most reports skip: the standard middle-distance event in the Commonwealth Games athletics programme is the 1500m, not the mile. Glasgow hosted the Games only in 2026. So if a report says mile final, either the event was actually the 1500m, or it was a special invitational race. When an event's name and distance are wrong, every comparison built on top of it is wrong too.

I trust the spreadsheet, but I do not let the story go un-audited. In 2026, sitting in a timing booth in Dhaka while I audited 47 years of federation results, I learned how a single number can make a legend—or break one. The gap between a hand-timed mark and an electronic one is not merely arithmetic; it is history. In Korir's case that gap is wider: on one side a placing, on the other a completely blank mark column.

Now the actual analysis. First conclusion: a placing is never a performance datum. Fifth means four people finished ahead. But how fast? Had a time existed, I could set it against the world record, the Commonwealth Games record, and the season's world lead. Without a time, elite or near-elite are estimates, not analysis.

Second conclusion, and the most important one: in Kenyan middle distance, the real barrier is not the final but selection. Kenya's women's middle-distance pool is so deep that reaching a Commonwealth final means she beat a crowd of equally capable runners inside her own country. That selection pressure is the real performance signal, not the fifth place. For a Kenyan athlete, clearing the selection gate is often harder than the championship final itself. Kenya's distance success rests on high-altitude camps, group training, and a cultural pipeline carried across generations. There, an athlete has to prove worthy at home first.

Third conclusion: Korir's real constraint is not competition, it is medicine. Continuous leakage from a congenital fistula is a training-availability shock, not a form dip. Middle-distance development stands on two pillars—aerobic volume and session consistency. Continuous leakage strikes the base of both. A long race means a long time on the track, and that is hardest for her. So she shortened her distances. Reducing distance here is a rational condition-management decision, not a performance strategy.

That is where the biggest unseen story hides. If she was forced to shorten her distances, then her true potential events—3000m, 5000m, or cross country—may have been abandoned for medical reasons, not performance reasons. Those are entirely different things. To measure an athlete's true ceiling, that distinction matters.

Fourth conclusion: there is a social layer that much analysis skips. She has said most people avoided her, and that she used sport so she would not feel excluded. That is a second-order performance factor. Social isolation and stigma affect training adherence and competitive readiness—a recognised point in sport psychology. When the stadium empties, the data can no longer hide behind the noise. In Korir's case the noise is sympathy and the data is blank; the two must be seen separately.

A comparison is needed here, because my own working field is Bangladesh. In Bangladesh we have never built a genuine middle-distance or distance pipeline. Eight divisional headquarters still have no synthetic track. Our distance runners do not even face the hand-timed versus electronic-timed dispute, because there is no competitive depth to dispute. In 2026, the Tokyo Olympic men's 100m entry standard was 10.05 seconds while Bangladesh's national record stood at 10.29—when I wrote about that 0.24-second gap, I understood our problem was an absence of depth. Kenya's problem is excess depth—a selection war; Bangladesh's problem is absent depth—an empty cell. They are not the same, and their solutions are not the same.

Now the risks that dominate this kind of reporting. First: mistaking a sympathy story for a performance story. Korir's achievement is survival; reaching the final is a result worth recognising. But reaching the final does not prove her condition has been beaten, nor that she has reached world-leading level despite the fistula. Cause and result blur here: the fistula did not make her a finalist, and being a finalist did not defeat the fistula. A placing can describe a person; it cannot explain her medical condition.

Second risk: confusion around the word fistula. The fistula most commonly discussed in East Africa is obstetric. Korir's is congenital—a structural condition. More important: fistula and DSD or testosterone-eligibility rules are entirely separate things. Eligibility rules for women's 400m–1500m have no relationship to Korir's physical condition. Merging the two would be a serious category error.

Third risk: the pity frame. A quote like most people avoided me can easily become a poor-thing story. That is a journalism risk, not an athlete's. Dignity-first, consent-based reporting matters here, because a physical condition and continence are sensitive health data.

Overall, the risk rating for this story is medium—but not because of competition or doping. Three reasons: (a) the career ceiling imposed by the medical condition, (b) verification risk on the core facts—name, placing, and event format are not independently confirmed, and (c) privacy and stigma. The first two are our measurement problem; the third is our writing problem.

What do I expect next? First, a time. If a valid 1500m mark for Korir appears at any meet, we can finally place her on a real benchmark—and only then can we say in numbers how heavy the word finalist really is. Second, a sign of federation or team medical support. There is no mention of any support structure for a long-term condition—that absence is itself information. The best models are janitors: they clean the context before they predict. Korir's context still needs one number, and nobody has written it yet.